{{Rsnum
|rsid=7784168
|Gene=POT1
|Chromosome=7
|position=124851984
|Orientation=plus
|GMAF=0.281
|Gene_s=POT1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 5.4 | 41.1 | 53.6
| HCB | 3.8 | 46.6 | 49.6
| JPT | 11.1 | 20.0 | 68.9
| YRI | 11.6 | 60.9 | 27.5
| ASW | 8.9 | 50.0 | 41.1
| CHB | 3.8 | 46.6 | 49.6
| CHD | 1.9 | 38.3 | 59.8
| GIH | 18.4 | 44.9 | 36.7
| LWK | 8.4 | 43.9 | 47.7
| MEX | 5.4 | 60.7 | 33.9
| MKK | 10.3 | 56.8 | 32.9
| TSI | 8.1 | 40.4 | 51.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=23907815
|Title=Prognostic impact of telomere maintenance gene polymorphisms in hepatocellular carcinoma patients with chronic Hepatitis B
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}